Biotech Update: RevMed, Roche, and Kyverna CAR-T Therapy Insights
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Latest Medicine stories from Life.
Stay informed with the latest developments in the biotech sector, featuring updates on RevMed, Roche, and Kyverna's CAR-T therapy.
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
Following the deaths of two US officials in a drug raid in Chihuahua, Mexico has initiated an investigation into potential constitutional violations and the US's involvement.
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development.
Strategic angle: A medieval ophthalmologist who translated Greek works by Galen, Hippocrates, and Plato into Arabic played a pivotal role in shaping Western medical scholarship, according to a study published in the journal Cogent Arts a
Strategic angle: Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious muscle-wasting condition that often accompanies it.
Strategic angle: Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, extending survival in preclinical models.